✦ LIBER ✦

Subcellular distribution of p210BCR-ABL in CML cell lines and primary CD34+ CML cells

✍ Scribed by Patel, H; Marley, S B; Greener, L; Gordon, M Y

Book ID: 110058567
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 764 KB
Volume: 22
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2405057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preferential sequestration in vitro of B

Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells

✍ Veena, P; Cornetta, K; Davidson, A; Agüero, B; McMahel, J; Traycoff, C M; Srour, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 357 KB

BCR-ABL activity and its response to dru

BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry

✍ Hamilton, A; Elrick, L; Myssina, S; Copland, M; Jørgensen, H; Melo, J V; Holyoak 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 183 KB

Synergistic activity of imatinib and 17-

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL – Inhibition of P-glycoprotein function by 17-AAG

✍ Radujkovic, A; Schad, M; Topaly, J; Veldwijk, M R; Laufs, S; Schultheis, B S; Ja 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 281 KB

Philadelphia chromosome-positive cells a

Philadelphia chromosome-positive cells are equally distributed in AC133+ and AC133− fractions of CD34+ peripheral blood progenitor cells from patients with CML

✍ Waller, CF; Martens, UM; Lange, W 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

Detection in primary chronic myeloid leu

Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2

✍ Hetal Patel; Stephen B. Marley; Myrtle Y. Gordon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

## Abstract Chronic myeloid leukemia (CML) arises as a consequence of the expression of a chimeric fusion protein, p210BCR‐ABL1, which is localized to the cytoplasm and has constitutive protein tyrosine kinase activity. Extensive publications report that p210BCR‐ABL1 complexed with multiple cytopla

PHA-680626 exhibits anti-proliferative a

PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases

✍ Artur Gontarewicz; Stefan Balabanov; Gunhild Keller; Jens Panse; Philippe Schafh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 818 KB